These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 26104074)

  • 1. Clinical Significance of Discrepancy between Arterial Spin Labeling Images and Contrast-enhanced Images in the Diagnosis of Brain Tumors.
    Abe T; Mizobuchi Y; Sako W; Irahara S; Otomi Y; Obama Y; Nakajima K; Khashbat D; Majigsuren M; Kageji T; Nagahiro S; Harada M
    Magn Reson Med Sci; 2015; 14(4):313-9. PubMed ID: 26104074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
    Xi YB; Kang XW; Wang N; Liu TT; Zhu YQ; Cheng G; Wang K; Li C; Guo F; Yin H
    Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Brain Tumor Contrast-enhancement on T1-CUBE and 3D-SPGR Images.
    Majigsuren M; Abe T; Kageji T; Matsuzaki K; Takeuchi M; Iwamoto S; Otomi Y; Uyama N; Nagahiro S; Harada M
    Magn Reson Med Sci; 2016; 15(1):34-40. PubMed ID: 26104076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of three-dimensional arterial spin labeling and how it compares against that of contrast enhanced magnetic resonance imaging in preoperative grading of brain gliomas.
    Wang K; Guo H; Tian X; Miao Y; Han P; Jin F
    Environ Toxicol; 2023 Jul; 38(7):1723-1731. PubMed ID: 37040330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of texture analysis on MRI in grading cerebral gliomas.
    Skogen K; Schulz A; Dormagen JB; Ganeshan B; Helseth E; Server A
    Eur J Radiol; 2016 Apr; 85(4):824-9. PubMed ID: 26971430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of pulsed-continuous arterial spin labeling and dynamic susceptibility contrast imaging by histogram analysis in evaluation of glial tumors.
    Arisawa A; Watanabe Y; Tanaka H; Takahashi H; Matsuo C; Fujiwara T; Fujiwara M; Fujimoto Y; Tomiyama N
    Neuroradiology; 2018 Jun; 60(6):599-608. PubMed ID: 29705876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of adding MRI data to WHO 2016 and cIMPACT-NOW updates for diffuse astrocytic tumors in adults. Working toward the extended use of MRI data in integrated glioma diagnosis.
    Roux A; Tran S; Edjlali M; Saffroy R; Tauziede-Espariat A; Zanello M; Gareton A; Dezamis E; Dhermain F; Chretien F; Lechapt-Zalcman E; Oppenheim C; Pallud J; Varlet P
    Brain Pathol; 2021 Jul; 31(4):e12929. PubMed ID: 33336392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroradiological viewpoint on the diagnostics of space-occupying brain lesions.
    Faehndrich J; Weidauer S; Pilatus U; Oszvald A; Zanella FE; Hattingen E
    Clin Neuroradiol; 2011 Sep; 21(3):123-39. PubMed ID: 21538040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences In High-Intensity Signal Volume Between Arterial Spin Labeling And Contrast-Enhanced T1-Weighted Imaging May Be Useful For Differentiating Glioblastoma From Brain Metastasis.
    Ganbold M; Harada M; Khashbat D; Abe T; Kageji T; Nagahiro S
    J Med Invest; 2017; 64(1.2):58-63. PubMed ID: 28373629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of MRS- and ASL-guided navigation for biopsy of intracranial tumors.
    Jin T; Ren Y; Zhang H; Xie Q; Yao Z; Feng X
    Acta Radiol; 2019 Mar; 60(3):374-381. PubMed ID: 29958510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
    Xing Z; You RX; Li J; Liu Y; Cao DR
    Clin Neuroradiol; 2014 Dec; 24(4):329-36. PubMed ID: 23994941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
    Ozsunar Y; Mullins ME; Kwong K; Hochberg FH; Ament C; Schaefer PW; Gonzalez RG; Lev MH
    Acad Radiol; 2010 Mar; 17(3):282-90. PubMed ID: 20060750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
    Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
    Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors.
    Sankar T; Moore NZ; Johnson J; Ashby LS; Scheck AC; Shapiro WR; Smith KA; Spetzler RF; Preul MC
    J Neurosurg; 2012 Jun; 116(6):1172-81. PubMed ID: 22424566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of arterial spin labelling MRI for discriminating atypical high-grade glioma from primary central nervous system lymphoma.
    Di N; Cheng W; Chen H; Zhai F; Liu Y; Mu X; Chu Z; Lu N; Liu X; Wang B
    Clin Radiol; 2019 Feb; 74(2):165.e1-165.e9. PubMed ID: 30415766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
    Warmuth C; Gunther M; Zimmer C
    Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
    You SH; Yun TJ; Choi HJ; Yoo RE; Kang KM; Choi SH; Kim JH; Sohn CH
    Eur Radiol; 2018 Sep; 28(9):3801-3810. PubMed ID: 29619520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.